Vimarsana
Biggest News Aggregation in the World

Page 16 - Equity Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Equity Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Equity Services Today - Breaking & Trending Today

Invesco BulletShares 2027 Municipal Bond ETF (NASDAQ:BSMR) Short Interest Down 91.6% in May - Vimarsana News

Invesco BulletShares 2027 Municipal Bond ETF (NASDAQ:BSMR) Short Interest Down 91.6% in May

Invesco BulletShares 2027 Municipal Bond ETF (NASDAQ:BSMR – Get Free Report) was the recipient of a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 700 shares, a drop of 91.6% from the April 30th total of 8,300 shares. Based on an average daily trading […]

Kratos Defense & Security Solutions (NASDAQ:KTOS) Sets New 52-Week High Following Analyst Upgrade - Vimarsana News

Kratos Defense & Security Solutions (NASDAQ:KTOS) Sets New 52-Week High Following Analyst Upgrade

Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS – Get Free Report)’s share price reached a new 52-week high on Tuesday after JPMorgan Chase & Co. raised their price target on the stock from $20.00 to $23.00. JPMorgan Chase & Co. currently has a neutral rating on the stock. Kratos Defense & Security Solutions traded as […]

Source: wkrb13.com
Autoliv (NYSE:ALV) Rating Increased to Buy at UBS Group - Vimarsana News

Autoliv (NYSE:ALV) Rating Increased to Buy at UBS Group

Autoliv (NYSE:ALV – Get Free Report) was upgraded by stock analysts at UBS Group from a “neutral” rating to a “buy” rating in a research note issued to investors on Tuesday, MarketBeat reports. The firm currently has a $141.00 price objective on the auto parts company’s stock, up from their previous price objective of $102.00. […]

Analysts Set Pyxis Oncology, Inc. (NASDAQ:PYXS) PT at $8.80 - Vimarsana News

Analysts Set Pyxis Oncology, Inc. (NASDAQ:PYXS) PT at $8.80

Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) have been given a consensus rating of “Buy” by the seven research firms that are covering the company, MarketBeat reports. Seven analysts have rated the stock with a buy recommendation. The average 1-year target price among brokers that have updated their coverage on the stock […]

Brokerages Set Dycom Industries, Inc. (NYSE:DY) Target Price at $175.86 - Vimarsana News

Brokerages Set Dycom Industries, Inc. (NYSE:DY) Target Price at $175.86

Shares of Dycom Industries, Inc. (NYSE:DY – Get Free Report) have earned a consensus rating of “Buy” from the eight analysts that are currently covering the company, Marketbeat reports. Seven analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year target price […]